Comparison of efficacy between homoharringtonine, aclarubicin, cytarabine (HAA) and idarubicin, cytarabine (IA) regimens as induction therapy in patients with de novo core binding factor acute myeloid leukemia.
Ann Hematol
; 102(10): 2695-2705, 2023 Oct.
Article
em En
| MEDLINE
| ID: mdl-37572135
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Leucemia Mieloide Aguda
/
Harringtoninas
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article